Skip to content
OpenCapital
Get started

Doximity DOCS Total cash and cash equivalents and marketable securities, Gross unrealized gains

Other financials

Income statement

See full
Revenue$145.4M+5.1%
Gross profit$126.0M+1.7%
Operating income$24.8M-49.0%
Net income$19.1M-69.4%
EPS (diluted)$0.10-67.7%

Balance sheet

See full
Cash & equivalents$219.2M+4.6%
Total debt$10.2M-17.8%
Total equity$950.8M-12.2%
Total assets$1.1B-11.1%

Cash flow

See full
Operating cash flow$109.5M+11.2%
CapEx-—
Free cash flow$81.6M-17.1%

Valuation

See full
Market cap$3.75B-60.5%

Profitability

See full
Gross margin89.1%-1.1pp
Operating margin33.3%-6.6pp
Net margin30.4%-8.7pp
FCF margin50.6%+2.7pp

Returns & leverage

See full
Return on equity19.3%-3.2pp
Debt / equity0×0.0×
Current ratio6.1×-0.9×

Where this comes from

Reported directly by Doximity in its filing.

Tagged under the XBRL concept docs:AssetsGrossUnrealizedGainsFairValueDisclosure.

The official record: Doximity’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →

Questions, answered.

What is Doximity's total cash and cash equivalents and marketable securities, gross unrealized gains?
Doximity (DOCS) reported total cash and cash equivalents and marketable securities, gross unrealized gains of $1.88M in Q4 2025.
How has Doximity's total cash and cash equivalents and marketable securities, gross unrealized gains changed year-over-year?
Doximity's total cash and cash equivalents and marketable securities, gross unrealized gains increased by 11.2% year-over-year, from $1.69M to $1.88M.